Andrew Stewart Plump sold $363K of Takeda Pharmaceutical Company Limited (TAK)

Executed Aug 19, disclosed Aug 21, 2 days later.

Value, as filed

$363K

19,651 sh × $18.49

Executed

Aug 19

the trade date, as filed

Disclosed

Aug 21

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Andrew Stewart Plump President, R&D profile →

Andrew Stewart Plump (President, R&D) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Takeda Pharmaceutical Company Limited (TAK). The largest single filing was $2.8M of TAK (165,393 sh × $17.10, as filed), executed Aug 10.

The name

TAK

Takeda Pharmaceutical Company Limited TAK · Healthcare · 19 filings in 24 months ticker →

Healthcare · Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical pro…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Andrew Stewart Plump in TAK

TAKSALE Takeda Pharmaceutical Company Limited $2.1M
116,191 sh × $18.49
Exec Sep 2
Filed Sep 3 · 9:49 PM ET TAKSALE Takeda Pharmaceutical Company Limited $2.8M
165,393 sh × $17.10
Exec Aug 10
Filed Aug 12 · 9:50 PM ET